about
Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesityZinc-α2-glycoprotein is unrelated to gestational diabetes: anthropometric and metabolic determinants in pregnant women and their offspring.Serum activin A and follistatin levels in gestational diabetes and the association of the Activin A-Follistatin system with anthropometric parameters in offspring.FGF-23/Vitamin D Axis in Type 1 Diabetes: The Potential Role of Mineral Metabolism in Arterial Stiffness.Cord blood FGF21 in gestational diabetes and its relationship with postnatal growth.A study of fatty acid binding protein 4 in HIV-1 infection and in combination antiretroviral therapy-related metabolic disturbances and lipodystrophy.A common gene variant in STK11 is associated with metabolic risk markers and diabetes during gestation.The tumour necrosis factor (TNF)-alpha system is activated in accordance with pulse pressure in normotensive subjects with type 1 diabetes mellitus.Insulin sensitivity and resistin levels in gestational diabetes mellitus and after parturition.Tumor Necrosis-Like Weak Inducer of Apoptosis as a Proinflammatory Cytokine in Human Adipocyte Cells: Up-Regulation in Severe Obesity Is Mediated by Inflammation But Not Hypoxia.Protein intake during aggressive calorie restriction in obesity determines growth hormone response to growth hormone-releasing hormone after weight loss.Parallel downregulation of retinol-binding protein-4 and adiponectin expression in subcutaneous adipose tissue of non-morbidly obese subjects.Reduced circulating levels of TWEAK are associated with gestational diabetes mellitus.A descriptive study of the characteristics of differentiated thyroid cancer in Catalonia during the period 1998-2012. The CECaT registry.Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery.Plasma visfatin concentrations increase in both hyper and hypothyroid subjects after normalization of thyroid function and are not related to insulin resistance, anthropometric or inflammatory parameters.Interleukin-6 in obese children and adolescents with and without glucose intolerance.Different TNFalpha expression elicited by glucose in monocytes from type 2 diabetes mellitus patients.Glycemic control and maternal and fetal outcomes in pregnant women with type 1 diabetes according to the type of basal insulin.Angiopoietin-like protein 8 (ANGPTL8) in pregnancy: a brown adipose tissue-derived endocrine factor with a potential role in fetal growth.Adipocyte fatty acid-binding protein as a determinant of insulin sensitivity in morbid-obese women.Accuracy of new recommendations for adrenal incidentalomas in the evaluation of excessive cortisol secretion and follow-upZinc alpha-2 glycoprotein is implicated in dyslipidaemia in HIV-1-infected patients treated with antiretroviral drugsInsulin resistance, low-grade inflammation and type 1 diabetes mellitusLower heart rate variability is associated with higher plasma concentrations of IL-6 in type 1 diabetesObstetric and perinatal outcome in women with twin pregnancy and gestational diabetesDehydroepiandrosterone sulphate, body fat distribution and insulin in obese men[Our experience in the nutritional treatment of anorexia nervosa (1989-1991)]Angiotensin I-converting enzyme levels and renin-aldosterone axis recovery after cessation of chronic licorice ingestionMonocyte chemoattractant protein-1 in obesity and type 2 diabetes. Insulin sensitivity studyIL-18: relationship with anthropometry, body composition parameters, leptin and arterial hypertensionDistribution and determinants of adiponectin, resistin and ghrelin in a randomly selected healthy populationLMNA mRNA expression is altered in human obesity and type 2 diabetesTumour necrosis factor receptors (TNFRs) in Type 2 diabetes. Analysis of soluble plasma fractions and genetic variations of TNFR2 gene in a case-control studyRelation between human LPIN1, hypoxia and endoplasmic reticulum stress genes in subcutaneous and visceral adipose tissueCorrection to: Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysisEarly Gestational Diabetes: is fasting glucose useful?Prevalence and risk factors for hypoparathyroidism following total thyroidectomy in Spain: a multicentric and nation-wide retrospective analysisGestational diabetes impacts fetal precursor cell responses with potential consequences for offspringMaternal Obesity Alters Placental Cell Cycle Regulators in the First Trimester of Human Pregnancy: New Insights for BRCA1
P50
Q28299330-41C1D858-FC47-4F00-937D-322624BC07BCQ34524768-32C5831F-31FD-48CF-A0A4-E2698A788AE8Q35156899-18E63783-782F-40F6-BDCE-A75AFED5A46EQ35804988-0534081C-BB93-459F-B044-52B22E5C37B9Q39052894-E473A329-744E-4428-8B15-138B641A4801Q44924827-E4BC5C45-E0EF-4D4E-A67D-615D11B17DCAQ46649331-0FA1F479-2FB4-48F2-ACBA-9BB78CBD1146Q46783903-3A3E092C-2383-4E59-8CF0-5EF8CE9FD03FQ46784161-10F2CC2D-A99D-48C5-B614-4ECB355F423EQ47164490-70123C56-92BF-437A-8893-7B502A489E51Q47389918-11F3CFE4-E34D-40A1-8A80-9E593C97822EQ48001998-71F52484-5DD8-43EE-AAA6-C32BCDA1CF5EQ50456399-233C137A-2005-43C2-878E-E1534CB74FABQ50554182-B8223F60-19CA-49FF-A047-28D4249823BAQ51083697-38F78A03-A9A3-4260-941A-5E98516CDF77Q51430990-5AC7A319-2D6D-411E-99E6-3368B03449B4Q51473577-532F8F0D-F342-4FEC-BFA8-BC5C459CEDDEQ51480197-74A0A3BE-C635-480E-84AC-B39671EE75ACQ51495575-9A2241C3-C0A8-4F2E-9459-6B10E73C01DBQ51609472-BD3DCFDC-C55C-48F2-8464-D4DCD5C7E4C8Q51837216-4F284CC6-68C1-4666-A983-0CC3FA0D6B53Q58563933-CF1D4612-8D91-4207-9957-9FA28F82C106Q59771038-86439568-1C9E-4626-A656-F1755EA48032Q60729970-9F185327-BC2D-409B-AC5A-2C34C37130DEQ60729979-10868BC6-2CEE-4390-B682-58E67A833A96Q61852126-B6200201-1B24-41CA-89A9-EB83BB90BE03Q72161343-8CB34816-9D5F-480A-8497-0C6BF2665273Q72445704-36CB96E7-65AD-435B-8036-82929A468FC8Q72624411-BF4D85FF-AE28-4FDE-9C2D-C9766A237048Q79986532-0B084F78-0480-463D-B9D8-3DE9B9655D7CQ80187195-F395EEAA-DD7D-48D6-A743-2C7003AEECD0Q81103628-32604F26-8E53-4339-9F8C-71C4E017BB7BQ81323297-1E695B97-582C-46F7-8734-E7F1E48D33CBQ81568188-EA259DEC-262C-4A6A-93C2-67944AD6E349Q82646111-254C5792-09F5-4261-B997-D107F9282DC7Q90893865-BD04725B-4474-4127-BA08-809630C168ACQ90907997-EFCEBAAA-B5A3-4BC0-9D26-4E3A5FE18669Q91979294-948E4599-9FF8-48E9-A486-7C6DA98A86B0Q92276830-B52C1F18-9A78-4331-B871-31134A980774Q92661447-D36B94F2-DD04-4AAE-94DD-C3B259F4B018
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Ana Megía
@ast
Ana Megía
@en
Ana Megía
@es
Ana Megía
@nl
Ana Megía
@sl
type
label
Ana Megía
@ast
Ana Megía
@en
Ana Megía
@es
Ana Megía
@nl
Ana Megía
@sl
altLabel
Ana Megia
@en
prefLabel
Ana Megía
@ast
Ana Megía
@en
Ana Megía
@es
Ana Megía
@nl
Ana Megía
@sl
P106
P1153
9336204300
P21
P31
P496
0000-0002-5101-9452